Tag: breast cancer

Dr. Stanislaw Burzynski’s “personalized gene-targeted cancer therapy”: Can he do what he claims for cancer?

Last week, I wrote a magnum opus of a movie review of a movie about a physician and “researcher” named Stanislaw Burzynski, MD, PhD, founder of the Burzynski Clinic and Burzynski Research Institute in Houston. I refer you to my original post for details, but in brief Dr. Burzynski claimed in the 1970s to have made a major breakthrough in cancer therapy...

/ December 5, 2011

Hope and hype in genomics and “personalized medicine”

“Personalized medicine.” You’ve probably heard the term. It’s a bit of a buzzword these days and refers to a vision of future medicine in which therapies are much more tightly tailored to individual patients than they currently are. That’s not to say that as physicians we haven’t practiced personalized medicine before; certainly we have. However it has only been in the last...

/ April 11, 2011

Death by “alternative” medicine: Who’s to blame? (Revisited)

(NOTE: There is now an addendum to this post.) (NOTE #2: The videos of Robert O. Young’s interview with Kim Tinkham have been removed, as I predicted in this post that they would be. Fortunately, I downloaded copies before he managed to do that. Part 6 appears to be still there–for now.) (NOTE #3: It was announced on the Facebook page Caring...

/ December 6, 2010
Thermography

Oprah’s buddy Dr. Christiane Northrup and breast thermography: The opportunistic promotion of quackery

Dr. Christiane Northrup came to fame as Oprah Winfrey's resident women's health expert. Unfortunately, she's using that fame to promote the unproven breast cancer screening modality thermography during Breast Cancer Awareness Month.

/ October 11, 2010

The mammography wars heat up again

PRELUDE: THE PROBLEM WITH SCREENING If there’s one aspect of science-based medicine (SBM) that makes it hard, particularly for practitioners, it’s SBM’s continual requirement that we adjust what we do based on new information from science and clinical trials. It’s not easy for patients, either. To lay people, SBM’s greatest strength, its continual improvement and evolution as new evidence becomes available, can...

/ September 27, 2010

Avastin and metastatic breast cancer: When science-based medicine collides with FDA regulation

Not all drugs that prevent progression of cancer prolong the patient's survival. The case of Avastin and metastatic breast cancer reminds us of that simple, unfortunate fact once again.

/ August 30, 2010

Abortion and breast cancer: The manufactroversy that won’t die

Whatever one thinks about abortion from a moral standpoint, we at SBM would argue that any discussion of the risks of abortion should be based in rigorous science. One "risk" of abortion frequently claimed by antiabortion activists is that it causes breast cancer, even if it takes science as bad as that found in a recently published epidemiological "study" on abortion and...

/ January 18, 2010

The Mammogram Post-Mortem

The Mammogram Post Mortem Steve Novella whimsically opined on a recent phone call that irrationality must convey a survival advantage for humans. I’m afraid he has a point. It’s much easier to scare people than to reassure them, and we have a difficult time with objectivity in the face of a good story. In fact, our brains seem to be hard wired...

/ December 10, 2009

The USPSTF recommendations for breast cancer screening: Not the final word

Preface: On issues such as this, I think it’s always good for me to emphasize my disclaimer, in particular: Dr. Gorski must emphasize that the opinions expressed in his posts on Science-Based Medicine are his and his alone and that all writing for this blog is done on his own time and not in any capacity representing his place of employment. His...

/ November 18, 2009

The cancer screening kerfuffle erupts again: “Rethinking” screening for breast and prostate cancer

I see that the kerfuffle over screening for cancer has erupted again to the point where it’s found its way out of the rarified air of specialty journals to general medical journals and hence into the mainstream press. Over the last couple of weeks, articles have appeared in newspapers such as the New York Times and Chicago Tribune, radio networks like NPR,...

/ November 2, 2009